Form 4 for BHC Bausch Health Companies Inc.
Accepted 2026-07-17 16:23:13 ET · period of report 2026-07-15 · accession 0000885590-26-000099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-17 16:23 | 2026-07-15 | BHC | Lenar Aimee J. | Pres, US Pharma | F - Tax | $4.89 | -23.4K | 376.9K | -6% | -$114.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2026-07-15 | F | D | 23,395 | $4.89 | 376,940 | D | — | — | (F1) This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. |